Trial Profile
An ascending dose study of erteberel in healthy men.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Nov 2015
Price :
$35
*
At a glance
- Drugs Erteberel (Primary)
- Indications Benign prostatic hyperplasia
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Eli Lilly and Company